"Our Mission" is to benefit patients.
"Our Vision" is to develop targeted medicines that offer patients and
physicians better, safer, more cost-effective healthcare.
By the pioneering efforts of team Themis and a renewed partnership with Gedeon Richter we are on a sustainable growth trajectory. The result is
Themis is well known for developing novel formulation and manufacturing APIs. The area of our focus is differentiated parenteral formulations and new drug delivery systems (NDDS) such as life saving drugs like EMAL, relatively painless injection like ETOJET, etc.
For all the innovations we have attained and milestones we have achieved, the real credit goes to our ever-evolving work force. It's our strong R&D team who has made all the difference with their specialized skills and dedication. Our Domestic Marketing team is striving to transform lives with their great talent, while the Export team is taking our endeavours to a new level by supporting the medical fraternity worldwide.
With a growing basket of new products, we have always focused on the core issues of critical therapies. It ensures that our partners focus on market expansion and discover new possibilities.
We promise unmatched quality by partnering (on CMO basis) with entities that have certified accreditation.
WHO-GMP | EUGMP | PICS